Stock·NYSE·Consumer Defensive
Philip Morris International Inc. (PM)
- Market cap
- $314.64B
- P/E
- 29.47
- Dividend yield
- 2.98%
- Street target
- $215.00median of 16 analysts
- 52-week range
- $142.11 $210.45
PM stock forecast today
Where PM stands today, and what CleaRank Financial AI makes of it.
PM at a glance
Philip Morris International Inc. (PM): Buy, 67/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($192.76 and $181.09).
- Earnings PM beat estimates in 4 of the 4 reports in our data, yet fell the next day after 2 of those beats.
- Insiders Insiders sold $28.8M and made no open-market purchases over the last 18 months.
- Valuation P/E of 29.5 against 24.2 for the Consumer Defensive sector: a premium to peers (+22%).
Figures as of October 26, 2026.
CleaRank Financial AI
Philip Morris International Inc. (PM) carries a CleaRank rating of Buy and a model score of 67/100.
Trend is the strongest contributor: the price stands 11.47% above its 200-day average and 4.72% above its 50-day average, while the 50-day average sits 6.45% above the 200-day. Valuation pulls the score down the most, with a P/E of 29.47 that is 21.8% above the sector median (a premium to peers) and a P/S of 7.29 that is 231.4% above the sector median. The 50-day average is $192.76 and the 200-day is $181.09. The price rose 28.07% over the past year.
Only on CleaRank
Figures we compute ourselves from PM's own price, earnings and insider-filing history. Tap one to see it in context.
PM stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
4/4Price above its 50-day average ›
The price of $201.87 is 4.7% above the 50-day simple moving average of $192.76.Price above its 200-day average ›
The price is 11.5% above the 200-day simple moving average of $181.09.50-day average above the 200-day ›
The 50-day average ($192.76) is 6.4% above the 200-day average ($181.09), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 87% of its 52-week range, between $142.11 and $210.45.
PM share price
Pick a period: each tab shows how far PM has moved over it, to the last close.
Today's trading
Where PM sits inside today's range and its 52-week range.
PM fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
3/5P/E below the sector median ›
The trailing P/E of 29.47 is 21.8% above the Consumer Defensive median of 24.2.P/S below the sector median ›
The price-to-sales ratio of 7.29 is 231.5% above the sector median of 2.2.Profitable over the last 12 months ›
Net income over the last 12 months was $10.7B on revenue of $43.1B, a net margin of 24.8%.Beat estimates in most recent reports ›
PM beat the EPS estimate in 4 of the 4 reports in our data.Pays a dividend ›
The trailing dividend yield is 2.98%, or $6.01 a share a year.
Key statistics
The headline figures for PM.
As of October 26, 2026, PM trades at $201.87, with a market value of $314.64B, a P/E ratio of 29.47 and a dividend yield of 2.98%.
What the numbers say
CleaRank Financial AI's reading of PM's valuation, growth and risks.
Against the 24.2 median P/E of Consumer Defensive stocks, PM's P/E of 29.47 is 21.8% above that median, which counts as a premium to peers. Measured against sales, the P/S of 7.29 is 231.4% above the sector median of 2.2. For scale, PM carries a market value of $314.6B and trailing earnings of $6.85 a share.
Profitability shows a net margin of 24.83% and an operating margin of 41.97%. It also reports a trailing dividend yield of 2.98% ($6.01 a share a year).
PM's most recent quarterly report, released on October 21, 2026, showed EPS of $2.36. Analysts had expected $2.32, so the company beat the estimate by 1.72%. The share price moved up 2.17% in the first session after the report.
The record is a clean sweep: 4 beats in 4 reports; even so, 2 of those 4 beats were followed by a lower share price the next session. Looking ahead, analysts expect EPS of $8.37 this fiscal year (growth of 11.0%) and $9.09 the year after (growth of 8.6%).
The valuation leaves little room for error, since the P/E of 29.47 is 21.8% above the sector median and counts as a premium to peers. A typical day moves the price of PM by 1.58%, the 30-day standard deviation of daily returns, and its beta against the S&P 500 is 0.36. Insiders sold $28.8M of stock over the last 18 months and made no open-market purchases. Insider sales are often planned in advance or made to cover tax on vesting shares, so they are a weaker signal than buying.
PM against the Consumer Defensive sector
How PM compares with the median Consumer Defensive stock CleaRank tracks.
Price to earnings vs sector: PM trades at a significant premium to sector peers (+22%), suggesting market expectations for superior growth or market position.
Return vs SPY: Since May 14, 2025, PM has gained 23.1% against a gain of 30.3% for SPY.
Performance against SPY
PM and the S&P 500 (SPY) over the same days.
Revenue and earnings
How much PM sells, and how much of it becomes profit.
The quarterly bars end with Q2 '26 (the quarter to June 30, 2026); PM reported again on October 21, 2026, and that quarter is not in our statement data yet. The 12-month figures come from the statistics feed and may include it.
Revenue growth: Revenue grew 7.3% in FY2025 to $40.6B, from $37.9B a year earlier.
Profit margin: The net margin was 29.1% in FY2025, up from 19.8% the year before.
Profitable: PM earned $11.8B in FY2025.
Earnings reality check
Did PM beat what analysts expected, and how did the stock react?
Earnings record: PM beat the analyst estimate in 4 of the 4 reports in our data.
Market reaction: The stock fell in the first session after 2 of those 4 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Oct 21, 2026after close | $2.32 | $2.36 | +1.72% | +2.17% | - |
| Jul 22, 2026after close | $2.05 | $2.20 | +7.32% | -1.64% | +2.13% |
| Apr 22, 2026after close | $1.83 | $1.96 | +7.10% | +3.20% | -0.76% |
| Jul 22, 2025after close | $1.86 | $1.91 | +2.69% | -0.36% | -1.52% |
As of October 26, 2026, PM has beaten the analyst EPS estimate in 4 of the 4 reports in our data and fell in the first trading session after 2 of those beats; its latest report, on October 21, 2026, came in 1.72% above the estimate and the stock moved +2.17% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
PM AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 56.8, in neutral territory.RSI above 50 ›
An RSI of 56.8 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank Financial AI analysis of PM
The score, the reasoning behind it, and what could move the price next.
PM is trading at $201.87, above both of its main moving averages. The price sits 4.72% above the 50-day average of $192.76 and 11.47% above the 200-day average of $181.09. Within its 52-week range the stock is at 87%, which leaves it 4.08% below the 52-week high of $210.45. The 50-day average is 6.45% above the 200-day average, meaning the shorter trend is pulling ahead of the longer one.
The recent returns all show a gain, with the price up 3.17% over the past three months, 25.46% over the past six months and 28.07% over the past year. On momentum, the 14-day RSI reads 56.8, in the neutral zone, with the MACD line positive.
Earnings beat ›
The October 21, 2026 report beat the EPS estimate by 1.72%, and the share price rose 2.17% in the first session after it.
Source: Earnings report, October 21, 2026
Rating reaffirmed ›
UBS kept its Neutral rating on October 22, 2026.
Source: Analyst action, UBS, October 22, 2026
- The two nearest levels matter most. The 52-week high at $210.45 is above the price, and the 20-day EMA at $198.11 is below it.
- The 14-day RSI reads 56.8, in the neutral zone, with the MACD line positive; readings above 70 or below 30 mark stretched momentum.
- PM's share price rose 2.17% in the first session after the October 21, 2026 report. Across the 4 reports in our data, the company beat estimates each time.
PM sits above its 50-day and 200-day moving averages ($192.76 and $181.09), and that position is why the trend reads up. A drop through the 50-day average would be the first sign of weakness. The closest support beneath the price is the 20-day EMA, at $198.11.
The next level overhead for PM is the 52-week high at $210.45. The 14-day RSI of 56.8 sits in the neutral zone, between 40 and 60.
Technical indicators
Momentum and trend for PM, from its daily closes.
As of October 26, 2026, with PM at $201.87, its 14-day RSI is 56.8 (neutral territory), its 50-day simple moving average is $192.76 and its 200-day is $181.09.
Calculated by CleaRank on daily closes as of October 26, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What PM moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 26, 2026, PM's 1-year correlation of daily returns is +0.00 with S&P 500 (SPY), -0.10 with Nasdaq 100 (QQQ), -0.04 with Bitcoin (BTC) and +0.00 with gold (XAU).
PM price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
12 of 16 analysts rate it a buy or strong buy, 4 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $215.00 is 6.5% above the price.More buy ratings than three months ago ›
12 of 16 rate it a buy now, against 12 of 16 three months ago.
PM Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 22, 2026 | UBS | Maintains | Neutral |
| Oct 22, 2026 | Needham | Maintains | Buy |
| Sep 23, 2026 | UBS | Maintains | Neutral |
| Jul 30, 2026 | Citigroup | Maintains | Buy |
| Jul 29, 2026 | Barclays | Maintains | Overweight |
| Jul 23, 2026 | Morgan Stanley | Maintains | Overweight |
As of October 26, 2026, 16 Wall Street analysts cover PM: 12 rate it a buy or strong buy, 4 a hold and 0 a sell or strong sell. Their 12-month price targets range from $175.00 to $230.00. The median PM price target is $215.00, 6.5% above the price of $201.87.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
PM trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
PM trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from PM's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much PM tends to move, against the market and on its own.
PM price history and drawdowns
PM's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
3/4Average daily move under 2% ›
The price has moved 1.58% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 40.6%, from June 2017 to December 2018, regained by June 2021.Most 1-year holds ended higher ›
72% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $34,243, against $42,015 in the S&P 500 (SPY).
PM Drawdowns & Recovery
As of October 26, 2026, PM's worst peak-to-trough fall over the last 10 years with dividends reinvested was -40.6% (June 2017 to December 2018); it regained that peak by June 2021, 30 months after the low, and 72% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into PM in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: PM trailed the S&P 500 over this period: $34,243 against $42,015.
A $10,000 investment in PM in October 2016 would be worth about $34,243 today with dividends reinvested, compared with about $42,015 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to PM, and which have not.
Strongest month, February: an average of +5.38%, up in 7 of 10 years.
Weakest month, September: an average of -2.42%, up in 2 of 10 years.
This month, October: has averaged +1.39%, up in 4 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, PM's strongest calendar month has been February (average +5.38%, up in 7 of 10 years) and its weakest September (average -2.42%, up in 2 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
PM stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in PM, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in PM today could grow to about $13,059 by 2030 in the base case, with a 90th-percentile outcome near $24,955 and a 10th-percentile outcome around $6,834. The simulation models price only; at today's 2.98% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
PM Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $264 for PM by 2030 in the base case, from $202 today (1.3x over 4 years). The 10th-percentile path ends near $138. These are outcomes of a Monte Carlo simulation run on PM's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $156 | $216 | $298 | |
| 2028 | $146 | $231 | $365 | |
| 2029 | $141 | $247 | $432 | |
| 2030 | $138 | $264 | $504 |
Method: a lognormal simulation of PM's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
PM insider trading
What the people running the company have bought and sold.
PM insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: No insider bought PM shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 26, 2026, PM insiders reported 6 open-market sales worth $28.8M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 6, 2026 | Bonin Bough
Director
|
Grant | 1.1K | $190.2K |
| May 6, 2026 | Andre Calantzopoulos
Chairman of the Board
|
Grant | 1.1K | $190.2K |
| May 6, 2026 | Michel Combes
Director
|
Grant | 1.1K | $190.2K |
| May 6, 2026 | Werner Geissler
Director
|
Grant | 1.1K | $190.2K |
| May 6, 2026 | Victoria D Harker
Director
|
Grant | 1.1K | $190.2K |
| May 6, 2026 | Lisa A. Hook
Director
|
Grant | 1.1K | $190.2K |
| May 6, 2026 | Kalpana Morparia
Director
|
Grant | 1.1K | $190.2K |
| May 6, 2026 | Robert Polet
Director
|
Grant | 1.1K | $190.2K |
| May 6, 2026 | Shlomo Yanai
Director
|
Grant | 1.1K | $190.2K |
| Feb 20, 2026 | Stacey Kennedy
Officer
|
Sell | 14.4K | $2.6M |
| Feb 20, 2026 | Reginaldo Dobrowolski
Officer
|
Sell | 6.0K | $1.1M |
| Feb 19, 2026 | Jacek Olczak
Officer and Director
|
Sell | 80.0K | $14.6M |
| Feb 19, 2026 | Emmanuel Babeau
Officer
|
Sell | 33.8K | $6.1M |
| Feb 19, 2026 | Wilde Frederic J De
Officer
|
Sell | 20.0K | $3.7M |
| Feb 19, 2026 | Yann Guerin
Officer
|
Sell | 4.0K | $726.8K |
| Feb 6, 2026 | Emmanuel Babeau
Officer
|
Grant | 61.4K | $2.0M |
| Feb 6, 2026 | Wilde Frederic J De
Officer
|
Grant | 33.1K | $1.8M |
| Feb 6, 2026 | Reginaldo Dobrowolski
Officer
|
Grant | 6.5K | $466.9K |
| Feb 6, 2026 | Yann Guerin
Officer
|
Grant | 8.3K | $873.3K |
| Feb 6, 2026 | Stacey Kennedy
Officer
|
Grant | 16.2K | $766.1K |
| Feb 6, 2026 | Jacek Olczak
Officer and Director
|
Grant | 171.0K | $5.8M |
| Feb 5, 2026 | Andre Calantzopoulos
Chairman of the Board
|
Grant | 40.1K | - |
| May 7, 2025 | Bonin Bough
Director
|
Grant | 1.0K | $175.2K |
| May 7, 2025 | Andre Calantzopoulos
Chairman of the Board
|
Grant | 1.0K | $175.2K |
| May 7, 2025 | Michel Combes
Director
|
Grant | 1.0K | $175.2K |
| May 7, 2025 | Werner Geissler
Director
|
Grant | 1.0K | $175.2K |
| May 7, 2025 | Victoria D Harker
Director
|
Grant | 1.0K | $175.2K |
| May 7, 2025 | Lisa A. Hook
Director
|
Grant | 1.0K | $175.2K |
| May 7, 2025 | Kalpana Morparia
Director
|
Grant | 1.0K | $175.2K |
| May 7, 2025 | Robert Polet
Director
|
Grant | 1.0K | $175.2K |
| May 7, 2025 | Dessislava Temperley
Director
|
Grant | 1.0K | $175.2K |
| May 7, 2025 | Shlomo Yanai
Director
|
Grant | 1.0K | $175.2K |
Source: TwelveData, from SEC Form 4 filings
PM stock forecast: questions people ask
Answered from the figures on this page, as of October 26, 2026.